ArticleRheumatology and therapy2021

Treatment of Active Idiopathic Inflammatory Myopathies by Low-Dose Interleukin-2: A Prospective Cohort Pilot Study.

Miao Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.